Pulmonary Hypertension and Pulmonary Vasodilators

Area of Science:

• Pediatric Cardiology
• Neonatology
• Pulmonology

Background:

• Pulmonary hypertension presents acutely (persistent pulmonary hypertension of the newborn) or chronically in the perinatal period.
• While acute pulmonary hypertension diagnosis is established, validated echocardiographic criteria for chronic forms are lacking.
• Infants with lung disease are at risk for chronic pulmonary hypertension and associated cardiovascular issues.

Purpose of the Study:

• To highlight the need for validated echocardiographic criteria for diagnosing chronic pulmonary hypertension in infants.
• To emphasize the importance of evaluating cardiovascular comorbidities in these infants.
• To address the uncertainty in treatment decisions without confirmed pulmonary vascular disease.

Main Methods:

• Review of current diagnostic standards for pulmonary hypertension in neonates.
• Analysis of echocardiographic utility in identifying chronic pulmonary hypertension.
• Discussion of the role of cardiac catheterization in diagnosis and comorbidity assessment.

Main Results:

• Existing echocardiographic criteria are insufficient for diagnosing chronic pulmonary hypertension in infants with lung disease.
• Cardiovascular comorbidities frequently accompany pulmonary hypertension and lung disease in infants.
• Confirmation of pulmonary vascular disease via cardiac catheterization is crucial for guiding treatment.

Conclusions:

• Validated echocardiographic criteria are urgently needed for chronic pulmonary hypertension in at-risk infants.
• Comprehensive evaluation including cardiac catheterization is essential for accurate diagnosis and management.
• Further research should focus on developing reliable diagnostic tools for this population.